These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 36174636)

  • 1. A survey on the patient perspective on cure in multiple myeloma.
    Mohyuddin GR; Ahlstrom JM; Chmielewski CA; Sweeney NW; Molina TH; Cheung CS; Ballard EW; Seng FF; Van Oekelen O; Godara A; McClune B; Sborov D
    Lancet Haematol; 2022 Oct; 9(10):e716-e719. PubMed ID: 36174636
    [No Abstract]   [Full Text] [Related]  

  • 2. Awareness of myeloma care and the global impact of treatment: An international internet-based prospective study.
    Ailawadhi S; Swaika A; Advani P; Hodge D; Paulus A; Khera N; Hashmi SK; Alegria VR; Abdulazeez M; Bodepudi S; Jamwal K; Roy V; Sher T; Chanan-Khan A; Ailawadhi M
    J Oncol Pharm Pract; 2022 Mar; 28(2):425-433. PubMed ID: 33719723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latest treatment strategies aiming for a cure in transplant-eligible multiple myeloma patients: how I cure younger MM patients with lower cost.
    Suzuki K
    Int J Hematol; 2020 Apr; 111(4):512-518. PubMed ID: 32125606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individual Trade-Offs Between Possible Benefits and Risks of Cancer Treatments: Results from a Stated Preference Study with Patients with Multiple Myeloma.
    Postmus D; Richard S; Bere N; van Valkenhoef G; Galinsky J; Low E; Moulon I; Mavris M; Salmonsson T; Flores B; Hillege H; Pignatti F
    Oncologist; 2018 Jan; 23(1):44-51. PubMed ID: 29079638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-reported outcomes in multiple myeloma.
    Lee SJ
    J Natl Compr Canc Netw; 2004 Jul; 2(4):379-83. PubMed ID: 19795600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-Reported Quality of Life and Symptom Burden in Ambulatory Patients With Multiple Myeloma on Disease-Modifying Treatment.
    Kiely F; Cran A; Finnerty D; O'Brien T
    Am J Hosp Palliat Care; 2017 Aug; 34(7):671-676. PubMed ID: 27141015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is it possible to cure myeloma without allogeneic transplantation?
    Katodritou E; Papadaki S; Konstantinidou P; Terpos E
    Transfus Apher Sci; 2016 Feb; 54(1):63-70. PubMed ID: 26850930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic Stem Cell Transplantation in Patients with High-Risk Multiple Myeloma: Utopia or Continuous Challenge in Aiming for Cure?
    Kaloyannidis P; Apostolidis J
    Curr Treat Options Oncol; 2021 Jun; 22(8):65. PubMed ID: 34110512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in the cultural adaptation of the German Myeloma Patient Outcome Scale (MyPOS): an outcome measure to support routine symptom assessment in myeloma care.
    Gerlach C; Taylor K; Ferner M; Munder M; Weber M; Ramsenthaler C
    BMC Cancer; 2020 Mar; 20(1):245. PubMed ID: 32293347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A cure for multiple myeloma?].
    Harousseau JL
    Presse Med; 2006 Sep; 35(9 Pt 2):1288-90. PubMed ID: 16969322
    [No Abstract]   [Full Text] [Related]  

  • 11. Multiple myeloma - current issues and controversies.
    Kumar S
    Cancer Treat Rev; 2010 May; 36 Suppl 2():S3-11. PubMed ID: 20472186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [On the road to cure of multiple myeloma?].
    Löwenberg B; Sonneveld P
    Ned Tijdschr Geneeskd; 1992 Apr; 136(14):669-71. PubMed ID: 1560851
    [No Abstract]   [Full Text] [Related]  

  • 13. Minimal residual disease testing in multiple myeloma by flow cytometry: major heterogeneity.
    Flanders A; Stetler-Stevenson M; Landgren O
    Blood; 2013 Aug; 122(6):1088-9. PubMed ID: 23929839
    [No Abstract]   [Full Text] [Related]  

  • 14. Bone marrow transplantation in multiple myeloma.
    Schlossman RL; Anderson KC
    Curr Opin Oncol; 1999 Mar; 11(2):102-8. PubMed ID: 10188074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extraordinary Progress in the Treatment of Multiple Myeloma: Is a Cure on the Horizon?
    Bergsagel PL
    Hematol Oncol Clin North Am; 2024 Apr; 38(2):xiii-xv. PubMed ID: 38171938
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of myeloma: cure vs control.
    Rajkumar SV
    Mayo Clin Proc; 2008 Oct; 83(10):1142-5. PubMed ID: 18828974
    [No Abstract]   [Full Text] [Related]  

  • 17. Understanding what matters most to people with multiple myeloma: a qualitative study of views on quality of life.
    Osborne TR; Ramsenthaler C; de Wolf-Linder S; Schey SA; Siegert RJ; Edmonds PM; Higginson IJ
    BMC Cancer; 2014 Jul; 14():496. PubMed ID: 25005145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fear of cancer recurrence in patients with multiple myeloma: Prevalence and predictors based on a family model analysis.
    Hu X; Wang W; Wang Y; Liu K
    Psychooncology; 2021 Feb; 30(2):176-184. PubMed ID: 32931646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of autologous peripheral blood stem cell transplantation for multiple myeloma: a multi-institutional survey].
    Inaba W; Shimazaki C
    Rinsho Ketsueki; 2002 May; 43(5):337-40. PubMed ID: 12096481
    [No Abstract]   [Full Text] [Related]  

  • 20. Asia-Pacific Hematology Consortium Report on approach to multiple myeloma. Survey results from the 6th International Hematologic Malignancies Conference: Bridging the Gap 2015, Beijing, China.
    Lu J; Hou J; Liu KY; Parmar S; De La Fuente A; Andersson B; Yan C; Zhou D; Tan D; Ritchie D; Wu D; Shpall E; Laport GG; Li J; Hu J; Zhang LS; Wang M; Malhotra P; Jiang Q; Qin Y; Wong R; Champlin R; Issaragrisil S; Iyer S; Mathews V; Wang Y; Hu Y; Xiao Z; Shao Z; Rosengarten R; Steuernagle J; Xiao JH; Orlowski R; Chim CS
    Leuk Lymphoma; 2016 Jul; 57(7):1534-8. PubMed ID: 26887657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.